Verastem (VSTM) Announces Stock Offering
Get Alerts VSTM Hot Sheet
Join SI Premium – FREE
Verastem, Inc., (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares to be sold in the offering are to be sold by Verastem.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Epic Gold plans $3.15M non-brokered private placement
- Blue Owl Technology Finance closes $150M senior unsecured notes
- Bilibili prices $700M convertible notes with Tencent participation
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share